Selective killing of SMARCA2- and SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type cells by inhibition of EZH2: In vitro and in vivo preclinical models.
Chan-Penebre, Elayne, Armstrong, Kelli, Drew, Allison, Grassian, Alexandra R, Feldman, Igor, Knutson, Sarah K, Kuplast-Barr, Kristy, Roche, Maria, Campbell, John, Ho, Peter, Copeland, Robert A, CheswoМова:
english
Журнал:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-16-0678
Date:
March, 2017
Файл:
PDF, 2.39 MB
english, 2017
File converter
Більше результатів пошуку
More benefits 
